摘要
美国国家综合癌症网络(NCCN)于2018年3月20日发布了2018年第1版《NCCN乳腺癌临床实践指南》。该指南结合乳腺癌领域最新的研究进展、新的循证医学证据和理念,在前期版本的基础上制定出当前乳腺癌诊治的指南与规范,供临床医师参考。笔者对最新版本中重要的变更内容进行解读,并结合中国的临床实际探讨其在中国推行的实用性和可行性,主要包括美国癌症联合会第8版乳腺癌TNM分期、保留乳房手术治疗和评估原则、前哨淋巴结活组织检查新进展和系统性治疗新策略4个方面。
The National Comprehensive Cancer Network（ NCCN） launched the NCCN Clinical Practice Guideline for Breast Cancer（ version 1） on March 20,2018. This guideline reviews the latest research progress and treatment concepts in the field of breast cancer. On the basis of the previous versions,they update the guidelines for the diagnosis and treatment of breast cancer,which can assist physicians in their clinical practices. This paper interpreted the important changes in the latest version,and discussed its practicability and feasibility in China based on clinical practice,including the TNM staging of breast cancer by American Joint Committee on Cancer（ AJCC）（ the eighth edition）, the principles of breast conserving surgery and pathological evaluation,the recent progress of sentinel lymph node biopsy and new strategy for systematic treatment.
作者
李俊杰
邵志敏
Li Junjie, Shao Zhimin.(Department of Breast Surgery, Affiliated Tumor Hospital of Fudan University, Shanghai 200032, China)
出处
《中华乳腺病杂志（电子版）》
CAS
CSCD
2018年第3期129-134,共6页
Chinese Journal of Breast Disease(Electronic Edition)
关键词
乳腺肿瘤
诊断
治疗学
指南
Breast neoplasms
Diagnosis
Therapeutics
Guideline
